DOCSLIB.ORG

AAPM REPORT NO. 54 STEREOTACTIC RADIOSURGERY Report of Task Group 42 Radiation Therapy Committee ,:. Michael C. Schell (Chairman

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
AAPM REPORT NO. 54 STEREOTACTIC RADIOSURGERY Report of Task Group 42 Radiation Therapy Committee ,:. Michael C. Schell (Chairman AAPM REPORT NO. 54 STEREOTACTIC RADIOSURGERY Report of Task Group 42 Radiation Therapy Committee ,:. Michael C. Schell (Chairman) Frank J. Bova David A. Larson (Consultant) Dennis D. Leavitt Wendell R. Latz Ervin B. Podgorsak Andrew Wu ! June 1995 Published for the AmericanAssociation of Physicists in Medicine by the American Institute of Physics STEREOTACTIC RAD1OSURGERY Table of Contents I. INTRODUCTION .................................................................................. 1 A. Clinical Introduction ..................................................................... 1 B. Introduction For Administrators ................................................... 3 If. RATIONALE FOR RADIOSURGICAL TREATMENTS ................... 4 A. Non-Malignant Lesions ................................................................. 5 B. Malignancies .................................................................................. 5 III. THE ACCURACY OF STEREOTACTIC RADIOSURGERY .......... 6 IV. STEREOTACTIC RADIOSURGERY TECHNIQUES ...................... 8 V. ACCEPTANCE TESTING ................................................................. 1 I ,',• A. Introduction .................................................................................. 1 1 B. Accurate Localization .................................................................. 1 1 DISCLAIMER: This publication is based on sources and information C. Mechanical Precision ................................................................... 1 1 believed to be reliable, but the AAPM and the editors disclaim any 1. Linac Gantry, Collimator, and Couch (PSA) ....................... 12 warranty or liability based on or relating to the contents of this 2. Lasers ...................................................................................... 12 publication. 3. Patient Docking Device ........................................................ 13 4. Frame Syste m :....... .:............................................................... 13 TheAAPMdoesnotendorseanyproducts, manufacturers, orsuppliers. 5. Target Verification Devices .................................................. 13 Nothing in this publication should be interpreted as implying such 6. SRS System Verification Test ............................................... 13 endorsement. D. Dose Delivery ............................................................................... 15 E. Patient Safety/Machine Interlocks ............................................. 15 Further copies of this report ($10 prepaid) may be obtained from: E Gamma Knife Acceptance Tests .................................................. 15 VI. DOSIMETRY .................................................................................... 16 A. Linac Systems ............................................................................... 16 American Association of Physicists in Medicine 1. Dose Measurements .............................................................. 16 One Physics Ellipse • Off-Axis Ratios .............................................................. 20 College Park, MD 20740-3843 • Scatter Correction Factors ............................................ 21 • Collimator Scatter .......................................................... 21 International Standard Book Number: 1-56396-497-X • Tissue-Maximum Ratios ............................................... 21 International Standard Serial Number: 0271-7344 B. Measurement Summary ............................................................... 21 1. Linacs ...................................................................................... 21 ©1995 by the American Association of Physicists in Medicine 2. Gamma Knife Units ............................................................... 22 3. Phantoms ................................................................................ 22 All rights reserved. No part of this publication may be reproduced, 4. Dosimetry Calculation .......................................................... 22 storedinaretrievalsystem, ortransmittedinanyformorbyanymeans • Planning Parameters ...................................................... 24 (electronic, mechanical, photocopying, recording, or otherwise) • Gamma Knife ................................................................. 25 without the prior written permission of the publisher. VII. QUALITY ASSURANCE ............................................................... 26 A. Introduction .................................................................................. 26 Published by the American Institute of Physics, Inc. B. Probable Risk Analysis and QA .................................................. 27 500 Sunnyside Blvd., Woodbury, NY 11797 C. Treatment QA ................................................................................ 28 1. Check Lists ............................................................................. 28 Printed in the United States of America 2. Target Position Verification .................................................. 30 ii i iii 3. Laser Check ............................................................................ 30 2. Couch-Mounted Frame System ............................................ 63 4. Pedestal Mount System ......................................................... 31 • Dynamic Stereotactic Radiosurgery 5. "Known" Target Test During Localization: Recommendation to SRS Manufacturers ............................. 31 at McGill University ...................................................... 63 6. Head Ring Movement Test ................................................... 32 C. Dedicated Radioisotope SRS Unit--The Gamma 7. Verification of Treatment Setup ........................................... 32 Knife Technique ........................................................................... 64 8. Secondary Test ....................................................................... 33 1. Apparatus ................................................................................ 64 D. Stereotactic Couch Mount ........................................................... 33 2. Target Localization ............................................................... 66 1. Overview ................................................................................ 33 3. Dose Calibrations and Measurements ................................. 66 2. Target Verification/The Joint Center for 4. Absorbed Dose Profiles ........................................................ 67 Radiation Therapy .................................................................. 34 5. Mechanical Alignment Accuracy ......................................... 70 3. Patient Alignment .................................................................. 35 6. Results .................................................................................... 70 4. Alignme_ht Verification of a Couch-Mounted XVI. Appendix V. EXAMPLE GAMMA-KNIFE QA PROGRAM .....71 Frame (McGill) ....................................................................... 36 XVII. Appendix VI. EXAMPLE RAD1OSURGERY E. Routine QA .................................................................................. 37 PROCEDURES AND CHECKLISTS ........................................ 72 E QA Program for a Gamma Knife ................................................. 39 XVIII.APPENDIXVII. DYNAMIC STEREOTACTIC BRAIN G. Stereotactic Frames and Quality Assurance .............................. 42 IRRADIATION PATIENT CHART (SAMPLE) ........................ 81 VIII. FUTURE DIRECTIONS ............................................................... 43 REFERENCES ............................................................................ 83 A. Image Correlation ........................................................................ 43 B. Multiple Fractionation ................................................................. 44 C. Real-Time Portal Imaging ............................................................ 45 D. Conformal SRS ............................................................................. 45 E. Robot-Guided Linac ..................................................................... 49 IX_ SUMMARY ...................................................................................... 49 X. ACKNOWLEDGEMENTS ................................................................ 50 XI. APPENDIX L PROBABLE RISK ANALYSIS FLOWCHART: EXAMPLE ........................................................................................ 5 I XlI.APPENDIX II. PROBABLE RISK ANALYSIS FLOWCHART: EXAMPLE ...................................................................................... 5 I XIII. APPENDIX Ilia. SRS QA SCHEDULE ....................................... 52 XlV. APPENDIX lllb, LINAC QA SCHEDULE ................................... 52 XV. APPENDIX IV. STEREOTACTIC RADIOSURGERY TECHNIQUES ................................................................................. 53 A. Heavy-Charged-Particle Therapy .............................................. 53 1. Heavy lons--LBL .................................................................. 53 2. ISAH: Irradiation Stereotactic Apparatus for Humans ...... 53 3. Beam Characteristics ..................................... ........................ 53 4. LBL Stereotactic Frame ................................ _....................... 54 5. Treatment ................................................................................ 56 B. Linear Accelerators in Radiosurgery ........................................
Load more

Recommended publications
  • 52571Anexoii-IV
    ANEXO II Precios medios de Embarcaciones a Motor usadas durante el primer año posterior a su matriculación Los precios de las embarcaciones se entienden sin tener en cuenta el valor del motor o equipo de motopropulsión Valores para el año 2017 * La potencia indicada en caballos de vapor (cv) no está expresada de acuerdo con lo establecido en el Sistema Legal de Unidades de Medida. Se proporciona el dato en cv Nota.- La potencia total = Nº x kW ( cv ) únicamente a nivel informativo y de forma transitoria debido a la costumbre. P R O P U L S I O N 2017 FABRICANTE/MARCA M O D E L O DIMENSIONES (m) Motor VALOR EUROS ESLORA MANGA CASCO TIPO Nº kW cv (*) ABBATE BRUNO 15 4,35 1,90 MONO FB 1 110 150 2.500 PRIMATIST PRIMATIST 15 4,50 1,90 MONO DFB 1 368 501 3.700 PRIMATIST 19 5,70 2,04 MONO DFB 1 368 501 9.300 PRIMATIST 19 5,70 2,04 MONO FB 1 129 176 11.100 PRIMATIST 19 CABINADO 5,70 2,04 MONO FB 1 129 176 13.500 PRIMATIST 23 7,06 2,36 MONO DFB 1 368 501 21.500 PRIMATIST 23 OPEN 7,06 2,40 MONO FB 1 147 200 16.500 PRIMATIST 23 7,47 2,40 MONO FB 1 243 331 18.500 PRIMATIST 25 7,47 2,42 MONO FB 1 243 331 18.500 PRIMATIST 25 CABINADO 7,47 2,42 MONO FB 1 243 331 20.300 PRIMATIST 27 8,09 2,58 MONO DFB 1 368 501 24.500 PRIMATIST 27 8,30 2,50 MONO FB 1 404 550 24.500 PRIMATIST 27 CABINADO 8,30 2,50 MONO DFB 2 191 260 30.700 PRIMATIST 29 CABINADO 8,43 2,58 MONO DFB 2 191 260 33.700 PRIMATIST 27 CABINA-FLYING BRID 8,80 2,58 MONO DFB 2 191 260 39.800 PRIMATIST 30 9,16 2,73 MONO DFB 1 368 501 30.700 PRIMATIST 30 CABINADO 9,30 2,60 MONO DFB 2 243 331 46.000
    [Show full text]
  • Submission to the Nuclear Power Debate Personal Details Kept Confidential
    Submission to the Nuclear power debate Personal details kept confidential __________________________________________________________________________________________ Firstly I wish to say I have very little experience in nuclear energy but am well versed in the renewable energy one. What we need is a sound rational debate on the future energy requirements of Australia. The calls for cessation of nuclear investigations even before a debate begins clearly shows that emotion rather than facts are playing a part in trying to stop the debate. Future energy needs must be compliant to a sound strategy of consistent, persistent energy supply. This cannot come from wind or solar. Lets say for example a large blocking high pressure weather system sits over the Victorian, NSW land masses in late summer- autumn season. We will see low winds for anything up to a week, can the energy market from the other states support the energy needs of these states without coal or gas? I think not. France has a large investment in nuclear energy and charges their citizens around half as much for it than Germany. Sceptics complain about the costs of storage of waste, they do not suggest what is going to happen to all the costs to the environment when renewing of derelict solar panels and wind turbine infrastructure which is already reaching its use by dates. Sceptics also talk about the dangers of nuclear energy using Chernobyl, Three Mile Island and Fuklushima as examples. My goodness given that same rationale then we should have banned flight after the first plane accident or cars after the first car accident.
    [Show full text]
  • 4. Particle Generators/Accelerators
    Joint innovative training and teaching/ learning program in enhancing development and transfer knowledge of application of ionizing radiation in materials processing 4. Particle Generators/Accelerators Diana Adlienė Department of Physics Kaunas University of Technolog y Joint innovative training and teaching/ learning program in enhancing development and transfer knowledge of application of ionizing radiation in materials processing This project has been funded with support from the European Commission. This publication reflects the views only of the author. Polish National Agency and the Commission cannot be held responsible for any use which may be made of the information contained therein. Date: Oct. 2017 DISCLAIMER This presentation contains some information addapted from open access education and training materials provided by IAEA TABLE OF CONTENTS 1. Introduction 2. X-ray machines 3. Particle generators/accelerators 4. Types of industrial irradiators The best accelerator in the universe… INTRODUCTION • Naturally occurring radioactive sources: – Up to 5 MeV Alpha’s (helium nuclei) – Up to 3 MeV Beta particles (electrons) • Natural sources are difficult to maintain, their applications are limited: – Chemical processing: purity, messy, and expensive; – Low intensity; – Poor geometry; – Uncontrolled energies, usually very broad Artificial sources (beams) are requested! INTRODUCTION • Beams of accelerated particles can be used to produce beams of secondary particles: Photons (x-rays, gamma-rays, visible light) are generated from beams
    [Show full text]
  • PART I GENERAL PROVISIONS R12 64E-5.101 Definitions
    64E-5 Florida Administrative Code Index PART I GENERAL PROVISIONS R12 64E-5.101 Definitions ................................................................................................. I-1 64E-5.102 Exemptions ............................................................................................. I-23 64E-5.103 Records ................................................................................................... I-24 64E-5.104 Tests ... ................................................................................................... I-24 64E-5.105 Prohibited Use ........................................................................................ I-24 64E-5.106 Units of Exposure and Dose ................................................................... I-25 64E-5 Florida Administrative Code Index 64E-5 Florida Administrative Code Index PART II LICENSING OF RADIOACTIVE MATERIALS R2 64E-5.201 ...... Licensing of Radioactive Material .............................................................. II-1 64E-5.202 ...... Source Material - Exemptions .................................................................... II-2 R12 64E-5.203 ...... Radioactive Material Other than Source Material - Exemptions ................. II-4 SUBPART A LICENSE TYPES AND FEES R12 64E-5.204 ..... Types of Licenses ..................................................................................... II-13 SUBPART B GENERAL LICENSES 64E-5.205 ..... General Licenses - Source Material .........................................................
    [Show full text]
  • Installation of the Cyclotron Based Clinical Neutron Therapy System in Seattle
    Proceedings of the Tenth International Conference on Cyclotrons and their Applications, East Lansing, Michigan, USA INSTALLATION OF THE CYCLOTRON BASED CLINICAL NEUTRON THERAPY SYSTEM IN SEATTLE R. Risler, J. Eenmaa, J. Jacky, I. Kalet, and P. Wootton Medical Radiation Physics RC-08, University of Washington, Seattle ~ 98195, USA S. Lindbaeck Instrument AB Scanditronix, Uppsala, Sweden Sumnary radiation areas is via sliding shielding doors rather than a maze, mai nl y to save space. For the same reason A cyclotron facility has been built for cancer a single door is used to alternately close one or the treatment with fast neutrons. 50.5 MeV protons from a other therapy room. All power supplies and the control conventional, positive ion cyclotron are used to b0m­ computer are located on the second floor, above the bard a semi-thick Beryllium target located 150 am from maintenance area. The cooler room contains a heat the treatment site. Two treatment rooms are available, exchanger and other refrigeration equipment. Not shown one with a fixed horizontal beam and one with an iso­ in the diagram is the cooling tower located in another centric gantry capable of 360 degree rotation. In part of the building. Also not shown is the hot lab addition 33 51 MeV protons and 16.5 - 25.5 MeV now under construction an an area adjacent to the deuterons are generated for isotope production inside cyclotron vault. It will be used to process radio­ the cyclotron vault. The control computer is also used isotopes produced at a target station in the vault. to record and verify treatment parameters for indi­ vidual patients and to set up and monitor the actual radiation treatment.
    [Show full text]
  • HISTORY Nuclear Medicine Begins with a Boa Constrictor
    HISTORY Nuclear Medicine Begins with a Boa Constrictor Marshal! Brucer J Nucl Med 19: 581-598, 1978 In the beginning, a boa constrictor defecated in and then analyzed the insoluble precipitate. Just as London and the subsequent development of nuclear he suspected, it was almost pure (90.16%) uric medicine was inevitable. It took a little time, but the acid. As a thorough scientist he also determined the 139-yr chain of cause and effect that followed was "proportional number" of 37.5 for urea. ("Propor­ inexorable (7). tional" or "equivalent" weight was the current termi­ One June week in 1815 an exotic animal exhibi­ nology for what we now call "atomic weight.") This tion was held on the Strand in London. A young 37.5 would be used by Friedrich Woehler in his "animal chemist" named William Prout (we would famous 1828 paper on the synthesis of urea. Thus now call him a clinical pathologist) attended this Prout, already the father of clinical pathology, be­ scientific event of the year. While he was viewing a came the grandfather of organic chemistry. boa constrictor recently captured in South America, [Prout was also the first man to use iodine (2 yr the animal defecated and Prout was amazed by what after its discovery in 1814) in the treatment of thy­ he saw. The physiological incident was common­ roid goiter. He considered his greatest success the place, but he was the only person alive who could discovery of muriatic acid, inorganic HC1, in human recognize the material. Just a year earlier he had gastric juice.
    [Show full text]
  • 22 Thesis Cyclotron Design and Construction Design and Construction of a Cyclotron Capable of Accelerating Protons
    22 Thesis Cyclotron Design and Construction Design and Construction of a Cyclotron Capable of Accelerating Protons to 2 MeV by Leslie Dewan Submitted to the Department of Nuclear Science and Engineering in Partial Fulfillment of the Requirements for the Degree of Bachelor of Science in Nuclear Science and Engineering at the Massachusetts Institute of Technology June 2007 © 2007 Leslie Dewan All rights reserved The author hereby grants to MIT permission to reproduce and to distribute publicly paper and electronic copies of this thesis document in whole or in part in any medium now known or hereafter created. Signature of Author: Leslie Dewan Department of Nuclear Science and Engineering May 16, 2007 Certified by: David G. Cory Professor of Nuclear Science and Engineering Thesis Supervisor Accepted by: David G. Cory Professor of Nuclear Science and Engineering Chairman, NSE Committee for Undergraduate Students Leslie Dewan 1 of 23 5/16/07 22 Thesis Cyclotron Design and Construction Design and Construction of a Cyclotron Capable of Accelerating Protons to 2 MeV by Leslie Dewan Submitted to the Department of Nuclear Science and Engineering on May 16, 2007 in Partial Fulfillment of the Requirements for the Degree of Bachelor of Science in Nuclear Science and Engineering ABSTRACT This thesis describes the design and construction of a cyclotron capable of accelerating protons to 2 MeV. A cyclotron is a charged particle accelerator that uses a magnetic field to confine particles to a spiral flight path in a vacuum chamber. An applied electrical field accelerates these particles to high energies, typically on the order of mega-electron volts.
    [Show full text]
  • The Supply of Medical Isotopes
    The Supply of Medical Isotopes AN ECONOMIC DIAGNOSIS AND POSSIBLE SOLUTIONS The Supply of Medical Isotopes AN ECONOMIC DIAGNOSIS AND POSSIBLE SOLUTIONS The Supply of Medical Isotopes AN ECONOMIC DIAGNOSIS AND POSSIBLE SOLUTIONS This work is published under the responsibility of the Secretary-General of the OECD. The opinions expressed and arguments employed herein do not necessarily reflect the official views of OECD member countries. This document, as well as any data and any map included herein, are without prejudice to the status of or sovereignty over any territory, to the delimitation of international frontiers and boundaries and to the name of any territory, city or area. Please cite this publication as: OECD/NEA (2019), The Supply of Medical Isotopes: An Economic Diagnosis and Possible Solutions, OECD Publishing, Paris, https://doi.org/10.1787/9b326195-en. ISBN 978-92-64-94550-0 (print) ISBN 978-92-64-62509-9 (pdf) The statistical data for Israel are supplied by and under the responsibility of the relevant Israeli authorities. The use of such data by the OECD is without prejudice to the status of the Golan Heights, East Jerusalem and Israeli settlements in the West Bank under the terms of international law. Photo credits: Cover © Yok_onepiece/Shutterstock.com. Corrigenda to OECD publications may be found on line at: www.oecd.org/about/publishing/corrigenda.htm. © OECD 2019 You can copy, download or print OECD content for your own use, and you can include excerpts from OECD publications, databases and multimedia products in your own documents, presentations, blogs, websites and teaching materials, provided that suitable acknowledgement of OECD as source and copyright owner is given.
    [Show full text]
  • The General Stud Book : Containing Pedigrees of Race Horses, &C
    ^--v ''*4# ^^^j^ r- "^. Digitized by tine Internet Arciiive in 2009 witii funding from Lyrasis IVIembers and Sloan Foundation http://www.archive.org/details/generalstudbookc02fair THE GENERAL STUD BOOK VOL. II. : THE deiterol STUD BOOK, CONTAINING PEDIGREES OF RACE HORSES, &C. &-C. From the earliest Accounts to the Year 1831. inclusice. ITS FOUR VOLUMES. VOL. II. Brussels PRINTED FOR MELINE, CANS A.ND C"., EOILEVARD DE WATERLOO, Zi. M DCCC XXXIX. MR V. un:ve PREFACE TO THE FIRST EDITION. To assist in the detection of spurious and the correction of inaccu- rate pedigrees, is one of the purposes of the present publication, in which respect the first Volume has been of acknowledged utility. The two together, it is hoped, will form a comprehensive and tole- rably correct Register of Pedigrees. It will be observed that some of the Mares which appeared in the last Supplement (whereof this is a republication and continua- tion) stand as they did there, i. e. without any additions to their produce since 1813 or 1814. — It has been ascertained that several of them were about that time sold by public auction, and as all attempts to trace them have failed, the probability is that they have either been converted to some other use, or been sent abroad. If any proof were wanting of the superiority of the English breed of horses over that of every other country, it might be found in the avidity with which they are sought by Foreigners. The exportation of them to Russia, France, Germany, etc. for the last five years has been so considerable, as to render it an object of some importance in a commercial point of view.
    [Show full text]
  • Cerebral Palsy and Stereotactic Neurosurgery: Long Term Results
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.52.1.23 on 1 January 1989. Downloaded from Journal ofNeurology, Neurosurgery, and Psychiatry 1989;52:23-30 Cerebral palsy and stereotactic neurosurgery: long term results J D SPEELMAN, J VAN MANEN From The Academic Medical Centre, Neurological Department, Amsterdam, The Netherlands SUMMARY A retrospective study was performed on a group of 28 patients with cerebral palsy, who had undergone a stereotactic encephalotomy for hyperkinesia or dystonia. The mean postoperative follow up period was 21 years (range: 12-27). Eighteen patients were available for follow up, nine had died, and one could not be traced. A positive result was obtained in eight ofthe 18 reassessed patients. Determining factors for the outcome were the degree of preoperative disability, side effects of the operation, and ageing since operation. The more favourable results were obtained in patients with hyperkinesia, tremor, and predominantly unilateral dystonia. Cerebral palsy, including the postnatal type, includes a Patiets and methods group of non-progressive disorders occurring at any Protected by copyright. stage of development and maturation of the brain up In the spring of 1986 a retrospective study was carried out to to the age of 4 years, causing impairment of motor analyse the outcome of stereotactic encephalotomy in 28 function. This impairment may include paresis, cerebral palsy patients, who had been operated upon during involuntary movement, lack of coordination or spas- the period 1958-74. Pre-operative clinical and operative data ticity. Other symptoms may contribute to the serious- are shown in table 1. ness of the disability, such as sensory disturbances, At the time of the first operation, eight patients were 5-14 intellectual impairment, reduced vision, deafness, years ofage, 10 patients 15-19 years, and 10 patients 20 years ofage or older.
    [Show full text]
  • Nrc Regulatory Issue Summary 2005-23 Clarification of the Physical Presence Requirement During Gamma Stereotactic Radiosurgery Treatments
    UNITED STATES NUCLEAR REGULATORY COMMISSION OFFICE OF NUCLEAR MATERIAL SAFETY AND SAFEGUARDS WASHINGTON, D.C. 20555 October 7, 2005 NRC REGULATORY ISSUE SUMMARY 2005-23 CLARIFICATION OF THE PHYSICAL PRESENCE REQUIREMENT DURING GAMMA STEREOTACTIC RADIOSURGERY TREATMENTS ADDRESSEES All gamma stereotactic radiosurgery (GSR) licensees. INTENT The U.S. Nuclear Regulatory Commission (NRC) is issuing this regulatory issue summary (RIS) to clarify the definition of the term “physically present,” as used in 10 CFR 35.615(f)(3). No specific action or written response is required. BACKGROUND In March 2005, during a licensing visit to a GSR facility, the NRC staff observed that the authorized medical physicist (AMP) did not remain physically present throughout one of the GSR treatments, as required by 10 CFR 35.615(f)(3). Instead, during the treatment, the AMP walked to the other end of the GSR suite and entered a treatment planning room located more than 30.5 meters (100 feet) away from the GSR treatment console. While discussing this incident with the licensee, the NRC staff recognized that the licensee was misinterpreting the physical presence requirement for GSR treatments. Based on the licensee’s interpretation of the regulations, the licensee considered any location within the GSR suite, including the treatment planning room, to be within hearing distance of normal voice from the GSR treatment console. The licensee believed that, within the contiguous boundary of its GSR suite, the human voice has sufficient volume, without electronic amplification, to alert the AMP of an emergency at essentially any location within its suite and the AMP could respond in a timely manner.
    [Show full text]
  • Cyclotrons: Old but Still New
    Cyclotrons: Old but Still New The history of accelerators is a history of inventions William A. Barletta Director, US Particle Accelerator School Dept. of Physics, MIT Economics Faculty, University of Ljubljana US Particle Accelerator School ~ 650 cyclotrons operating round the world Radioisotope production >$600M annually Proton beam radiation therapy ~30 machines Nuclear physics research Nuclear structure, unstable isotopes,etc High-energy physics research? DAEδALUS Cyclotrons are big business US Particle Accelerator School Cyclotrons start with the ion linac (Wiederoe) Vrf Vrf Phase shift between tubes is 180o As the ions increase their velocity, drift tubes must get longer 1 v 1 "c 1 Ldrift = = = "# rf 2 f rf 2 f rf 2 Etot = Ngap•Vrf ==> High energy implies large size US Particle Accelerator School ! To make it smaller, Let’s curl up the Wiederoe linac… Bend the drift tubes Connect equipotentials Eliminate excess Cu Supply magnetic field to bend beam 1 2# mc $ 2# mc " rev = = % = const. frf eZion B eZion B Orbits are isochronous, independent of energy ! US Particle Accelerator School … and we have Lawrence’s* cyclotron The electrodes are excited at a fixed frequency (rf-voltage source) Particles remain in resonance throughout acceleration A new bunch can be accelerated on every rf-voltage peak: ===> “continuous-wave (cw) operation” Lawrence, E.O. and Sloan, D.: Proc. Nat. Ac. Sc., 17, 64 (1931) Lawrence, E.O. & Livingstone M.S.: Phys. Rev 37, 1707 (1931). * The first cyclotron patent (German) was filed in 1929 by Leó Szilard but never published in a journal US Particle Accelerator School Synchronism only requires that τrev = N/frf “Isochronous” particles take the same revolution time for each turn.
    [Show full text]